Baxter International Inc , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
infoBaxter International is a large cap stock with a total market cap of 20.97B.
infoThey trade on the NYSE and had their IPO 41 years and 9 months ago.
infoBaxter International currently employs 60000 people.
infoAs of Wednesday, Aug 23 2023, Baxter International’s share price is $41.41.
News Relating to Baxter International
Business Wire
Baxter to Present at 2023 Wells Fargo Healthcare Conference
Tuesday Aug 22 2023 at 16:15
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer is scheduled to present at 8:45 a.m. EST. The live webcast of Baxter’s presentation can be accessed at http://www.baxter.com and will be available for replay through March 5, 2024. About Baxter Every day, millions of patients and caregive.
Seeking Alpha
Dividend Challengers Review: Baxter International
Monday Aug 14 2023 at 16:33
Baxter International has seen 7 consecutive years of dividend growth, but has not raised its dividend this year. The company’s financials show slow revenue growth and a dramatic drop in earnings. Baxter’s stock price has declined significantly over the past five years, making it a less attractive investment option compared to peers.
Zacks Investment Research
Baxter (BAX) Beats on Q2 Earnings, Revises 2023 EPS Guidance
Thursday Jul 27 2023 at 11:42
Baxter’s (BAX) second-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.
Zacks Investment Research
Baxter (BAX) to Post Q2 Earnings: What’s in the Offing?
Friday Jul 21 2023 at 11:27
Baxter’s (BAX) second-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom’s products might have boosted sales.
Zacks Investment Research
Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline
Thursday Jul 20 2023 at 11:26
Baxter (BAX) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlace
3 Dividend Growth Stocks Raising Dividends
Friday Jul 07 2023 at 12:52
Income investors tend to focus on stocks with high dividend yields. This is understandable, as investors such as retirees need current income.
Zacks Investment Research
Baxter’s (BAX) New Launch to Support Complex Critical Care Needs
Friday Jun 30 2023 at 12:12
Baxter’s (BAX) Progressa+ bed for the ICU is expected to enhance workflow and reduce strain on nursing resources.
Seeking Alpha
Dividend Champion, Contender, And Challenger Highlights: Week Of June 25
Sunday Jun 25 2023 at 10:28
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Business Wire
Baxter to Host Second-Quarter 2023 Financial Results Conference Call for Investors
Tuesday Jun 13 2023 at 16:30
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2023 financial results on Thursday, July 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/XvgzXupv to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at http://www.baxter.com.
Seeking Alpha
Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Monday Jun 12 2023 at 19:02
Baxter International Inc plans to divest its BioPharma Solutions business for $4.25 billion, aiming to pay down its long-term debt and create room for further growth. The company’s robust margins and cash flows, along with a diverse product portfolio, make it an attractive option for a dividend-oriented portfolio. Despite the risks associated with the large amount of debt on the balance sheet, Baxter International Inc is rated as a buy due to its stable dividend yield and potential for share appreciation.
Business Wire
Baxter to Present at Jefferies Healthcare Conference
Wednesday May 24 2023 at 16:15
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at http://www.baxter.com and will be available for replay through Wednesday, September 6, 2023. About Baxter Every day, millions of patients a.
Market Watch
Baxter to sell its BioPharma business for $4.25 billion to Advent International, Warburg Pincus as part of ‘transformation journey’
Monday May 08 2023 at 10:14
Shares of Baxter International Inc. BAX rose 1.2% in premarket trading Monday, after the health care products company announced an agreement to divest its BioPharma Solutions business to private-equity investor Advent International and Warburg Pincus. Under terms of the agreement, Baxter will receive $4.25 billion in cash, which the company plans to use to pay down debt.
Zacks Investment Research
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
Tuesday May 02 2023 at 12:57
Investors interested in stocks from the Medical – Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Seeking Alpha
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript
Thursday Apr 27 2023 at 12:11
Baxter International Inc. (BAX) Q1 2023 Earnings Call Transcript.
Zacks Investment Research
Are Investors Undervaluing Baxter International (BAX) Right Now?
Tuesday Apr 25 2023 at 11:29
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research
Baxter (BAX) to Post Q1 Earnings: What’s in the Offing?
Thursday Apr 20 2023 at 08:23
Baxter’s (BAX) first-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom’s products might have boosted sales.
Business Wire
Baxter to Present at BofA Securities 2023 Health Care Conference
Wednesday Apr 19 2023 at 16:15
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at http://www.baxter.com and will be available for replay through November 5, 2023.
Seeking Alpha
3 Reasons To Consider A Nibble On Baxter
Tuesday Apr 11 2023 at 14:43
H1-23 is likely to be challenging, but drastic adjustments have already been made to forward estimates, with valuations now looking attractive. FCF could double in FY23 as working capital dynamics pick up, and the potential sale of BPS could also help reduce debt levels.
Zacks Investment Research
Baxter’s (BAX) New Premix Drug Now Available in the U.S.
Monday Apr 10 2023 at 12:56
Baxter’s (BAX) latest frozen premix formulation is expected to support patient safety, simplify medication preparation and boost operational efficiencies.
Business Wire
Baxter to Host First-Quarter 2023 Financial Results Conference Call for Investors
Thursday Apr 06 2023 at 16:15
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2023 financial results on Thursday, April 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/WhpPxesO to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at http://www.baxter.
Seeking Alpha
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
Saturday Mar 25 2023 at 10:44
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Reuters
Exclusive: Thermo Fisher, Celltrion vie for Baxter’s biopharma unit -sources
Monday Mar 20 2023 at 17:43
U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among
The Motley Fool
Is It Time to Buy the S&P 500’s 4 Worst-Performing Stocks of 2023?
Sunday Mar 05 2023 at 07:38
Lumen’s slowing growth, high debt, and dividend cut spooked the bulls. Moderna and Pfizer both face tough post-pandemic slowdowns.
Seeking Alpha
Dividend Champion, Contender, And Challenger Highlights: Week Of February 19
Sunday Feb 19 2023 at 02:13
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
The Motley Fool
Why Baxter International Stock Sank by 12% This Week
Friday Feb 10 2023 at 17:33
Macroeconomic woes were taking a toll on the medical tech company.
Seeking Alpha
Baxter International Inc. (BAX) Q4 2022 Earnings Call Transcript
Thursday Feb 09 2023 at 13:53
Baxter International Inc. (NYSE:BAX ) Q4 2022 Earnings Conference Call February 9, 2023 8:30 AM ET Company Participants Clare Trachtman – Vice President of Investor Relations José Almeida – Chairman, President & Chief Executive Officer James Saccaro – Executive Vice President & Chief Financial Officer Conference Call Participants Pito Chickering – Deutsche Bank Robbie Marcus – JPMorgan Vijay Kumar – Evercore ISI Matthew Mishan – KeyBanc Matt Miksic – Barclays Lawrence Biegelsen – Wells Fargo Operator Good morning ladies and gentlemen and welcome to Baxter International’s Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material.
Zacks Investment Research
Baxter (BAX) Q4 Earnings Miss Estimates, FY23 Outlook Weak
Thursday Feb 09 2023 at 12:49
Baxter’s (BAX) fourth-quarter results reflect impact of additional sales from the legacy Hilrom’s business acquired in 2021. Ongoing macroeconomic challenges hurt earnings significantly.
Zacks Investment Research
Baxter International (BAX) Lags Q4 Earnings Estimates
Thursday Feb 09 2023 at 09:48
Baxter (BAX) delivered earnings and revenue surprises of -6.38% and 3.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
24/7 Wall Street
5 Best and Worst Performing Health Care Stocks in December 2022
Monday Jan 23 2023 at 22:51
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.
Seeking Alpha
I’ll Avoid These Sectors In 2023
Sunday Jan 15 2023 at 03:39
I wrote an article about which sectors I intend to focus on for this year, with a number of example picks for each sector. In this article, it’s the opposite. I will show you what sectors I will try to avoid, given volatility or negative potential for these sectors.
Baxter International Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Baxter International’s Altman Z-score is 1.96 which is in the gray zone. This indicates a level of ambiguity where further analyses are needed to evaluate the company’s financial stability accurately.
Derived from SEC.GOV filing dataopen_in_new
Baxter International Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, there has been no insider trading in Baxter International.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Baxter International’s Income Quality of -0.42 is lower than its Industry Group of 0.68 (-161.8% lower)
Baxter International’s Income Quality of -0.42 is lower than its Major Industry Group of 0.71 (-159.2% lower)
Baxter International’s Income Quality of -0.42 is lower than its Sector of 0.75 (-156.0% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Baxter International’s Current Ratio of 1.42 is lower than its Industry Group of 3.36 (-57.7% lower)
Baxter International’s Current Ratio of 1.42 is lower than its Major Industry Group of 3.13 (-54.6% lower)
Baxter International’s Current Ratio of 1.42 is lower than its Sector of 2.6 (-45.4% lower)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-7.36 & -1.02)
Cannot compare a negative PE Ratio (-7.36 & -0.58)
Cannot compare a negative PE Ratio (-7.36 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Baxter International’s PB Ratio of 3.72 is greater than its Industry Group of 1.9 (95.8% greater)
Baxter International’s PB Ratio of 3.72 is greater than its Major Industry Group of 1.93 (92.7% greater)
Baxter International’s PB Ratio of 3.72 is greater than its Sector of 1.62 (129.6% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Baxter International’s ROE of -0.51 is lower than its Industry Group of -0.26 (-96.2% lower)
Baxter International’s ROE of -0.51 is lower than its Major Industry Group of -0.09 (-466.7% lower)
Baxter International’s ROE of -0.51 is lower than its Sector of -0.03 (-1600.0% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Baxter International’s ROCE of -0.01 is greater than its Industry Group of -0.27 (96.3% greater)
Baxter International’s ROCE of -0.01 is greater than its Major Industry Group of -0.14 (92.9% greater)
Baxter International’s ROCE of -0.01 is greater than its Sector of -0.04 (75.0% greater)
Derived from SEC.GOV filing dataopen_in_new